<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01897649</url>
  </required_header>
  <id_info>
    <org_study_id>ROQ_NUTRIFLORE10</org_study_id>
    <nct_id>NCT01897649</nct_id>
  </id_info>
  <brief_title>Effect of 15g Daily Consumption of NUTRIOSE on Healthy Volunteers Microbiota.</brief_title>
  <acronym>ROQ_NUTRIFLORE</acronym>
  <official_title>Effect of 15g Daily Consumption of NUTRIOSE During 2 and 4 Weeks on Healthy Volunteers Microbiota and Digestive Tolerance.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nealth Sarl</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Roquette Freres</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nealth Sarl</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      NUTRIOSE is a food ingredient defined as a carbohydrate polymer of vegetable origin (wheat
      starch or corn) with a degree of polymerization ≥ 3 and chemically transformed. It is soluble
      in aqueous solution, very poorly digested in the small intestine, it mostly reaches the colon
      where it stimulates fermentation. AFSSA, in its opinion of July 30, 2007, considers that this
      ingredient is a &quot;soluble dietary fiber.&quot; The objective of this research is to determine,
      among healthy subjects, the effect of this dietary fiber on changes in gut microbiota and
      digestive tolerance during a 28 days consumption. Microbiological analyzes will be performed
      by RT-PCR. Digestive tolerance will be measured by the intelligence of a questionnaire by
      volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clostridium Perfringens rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>digestive tolerance</measure>
    <time_frame>J0 to J28 (every day)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>stool pH</measure>
    <time_frame>D0 ; D14; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>total stool flora</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bacteroides rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eubacterium rectal rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clostridium coccoides rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clostridium leptum rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bifidobacteria rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactobacteria rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Streptococcus rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Enterococcus rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bacteroidetes rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actinobacteria rate in stool</measure>
    <time_frame>D0 ; D14; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Firmicutes rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E. Coli rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clostridium difficile rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Faecalibacterium prausnitzii rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clostridium difficile typa A and B rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E. Coli EIEC + EPEC (eae gene) rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Shigella + E. Coli EIEC (ipaH gene) rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Listeria Monocytogenes rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Yersinia Enterocolitica rate in stool</measure>
    <time_frame>D0 ; D14 ; D28</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Microbiota</condition>
  <condition>Dietary Fibers</condition>
  <arm_group>
    <arm_group_label>NUTRIOSE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group of volunteers fed with NUTRIOSE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>GLUCIDEX</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>gruop of volunteers fed with GLUCIDEX</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>NUTRIOSE FB06</intervention_name>
    <description>15g/day NUTRIOSE FB06</description>
    <arm_group_label>NUTRIOSE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>GLUCIDEX 21</intervention_name>
    <description>15g/day GLUCIDEX 21</description>
    <arm_group_label>GLUCIDEX</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 20 to 50 years,

          -  BMI 18 to 25 kg/m2,

          -  absence of known or scalable organic or psychiatric disease

          -  no history of chronic gastrointestinal disease

          -  having a bowel regularity (1-3 defecation per day, of normal consistency),

          -  person without medication during the study (especially laxatives, anti diarrheal)
             (except contraceptives in women)

          -  having normal laboratory hepatic and renal tests (ASAT, ALAT, GGT, urea, creatinine)

          -  no pregnant nor nursing women

          -  covered by Social Security

          -  negative serology for hepatitis B/C and HIV

          -  who signed the informed consent form

        Exclusion Criteria:

          -  persons abusing drugs (laxatives, anti-diarrheal)

          -  person who doesn't want to stop taking food supplements containing pre- or probiotics
             during time of the study

          -  person intolerant to gluten and / or allergic to wheat flour

          -  person in vegetarian or vegan diet

          -  Inclusion in another clinical study

          -  subjects receiving over 4,500 Euros in the last 12 months (including the present
             study)

          -  subjects presenting risk of non-compliance in the opinion of the recruiting doctor.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert BENAMOUZIG, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de Recherche en Nutrition Humaine d'Ile-de-France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Avicenne- Centre de Recherche Sur Volontaires-Service de Gastroenterologie</name>
      <address>
        <city>Bobigny</city>
        <zip>93009</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Li S, Guerin-Deremaux L, Pochat M, Wils D, Reifer C, Miller LE. NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in overweight men: a double-blind, randomized, placebo-controlled study. Appl Physiol Nutr Metab. 2010 Dec;35(6):773-82. doi: 10.1139/H10-074.</citation>
    <PMID>21164548</PMID>
  </reference>
  <reference>
    <citation>Guerin-Deremaux L, Li S, Pochat M, Wils D, Mubasher M, Reifer C, Miller LE. Effects of NUTRIOSE® dietary fiber supplementation on body weight, body composition, energy intake, and hunger in overweight men. Int J Food Sci Nutr. 2011 Sep;62(6):628-35. doi: 10.3109/09637486.2011.569492. Epub 2011 May 19.</citation>
    <PMID>21591985</PMID>
  </reference>
  <reference>
    <citation>Pasman W, Wils D, Saniez MH, Kardinaal A. Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men. Eur J Clin Nutr. 2006 Aug;60(8):1024-34. Epub 2006 Feb 15.</citation>
    <PMID>16482066</PMID>
  </reference>
  <reference>
    <citation>Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005 May;71(5):2318-24.</citation>
    <PMID>15870317</PMID>
  </reference>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2013</study_first_submitted>
  <study_first_submitted_qc>July 9, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 12, 2013</study_first_posted>
  <last_update_submitted>July 9, 2013</last_update_submitted>
  <last_update_submitted_qc>July 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>functional food</keyword>
  <keyword>digestive tolerance</keyword>
  <keyword>microbiota</keyword>
  <keyword>bifidogenic effect</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

